Discordance between adiposity and FIB-4 risk classification in US adults
Authors:
- Luyu XieLXLuyu Xie
- Diego AnazcoDADiego Anazco
- Azucena Herrera ChancayACAzucena Herrera Chancay
- Sarah E. MessiahSMSarah E. Messiah
- Jaime P. AlmandozJAJaime P. Almandoz
Open Access
- 8 July 2026
- journal article
- Published by Springer Nature in Journal of Diabetes & Metabolic Disorders
- Vol. 25 (2)
Abstract
Purpose: The fibrosis-4 index (FIB-4) is a widely used noninvasive tool for fibrosis risk stratification, however, the relationship between adiposity and FIB-4-based risk classification remains unclear. We evaluated the associations between multiple measurements of adiposity and FIB-4 risk classification in a nationally representative sample of U.S. adults. Methods: We analyzed data from 10,711 adults aged 35–65 years from the 2011–2018 NHANES. Examined anthropometric measures included body mass index (BMI), total body fat percentage (TBFP), waist circumference (WC), and waist-to-hip ratio (WH). We conducted logistic regression models to evaluate the association between anthropometric measurements and high-risk FIB-4 classification and to assess whether these associations differed by age group. Results: Most participants had low-risk FIB-4 scores (72.9%), followed by intermediate-risk (25.1%) and high-risk (2%). Individuals with low FIB-4 risk classification had higher BMI, TBFP and WC ( p < 0.01). In interaction models, the inverse associations between adiposity measures and high-risk FIB-4 classifications varied by age group. Among adults aged 51–65 years, higher BMI and TBFP were associated with lower odds of high-risk FIB-4 classification, whereas these associations were not significant for adults aged 35–50 years. Conclusion: Higher adiposity was associated with lower likelihood of high-risk FIB-4 classification. Age-stratified analyses suggested a potential discordance in the association between adiposity and FIB-4 risk classification across age groups. These findings suggest a potential discordance between adiposity-related metabolic risk and FIB-4-based risk classification, suggesting the need for age- and adiposity-informed risk assessment strategies for individuals at risk for hepatic fibrosis.Keywords
Funding Information
- National Institutes of Health (1P30DK127984-01A1)
- National Institutes of Health (1P30DK127984-01A1)
- National Institutes of Health (1P30DK127984-01A1)
- National Institutes of Health (1P30DK127984-01A1)
- National Institutes of Health (1P30DK127984-01A1)
This publication has 12 references indexed in Scilit:
- A Comparison of the Predictive Value of 12 Body Composition Markers for Metabolic Dysfunction-Associated Steatotic Liver Disease, At-Risk Metabolic Dysfunction-Associated Steatohepatitis, and Increased Liver Stiffness in a General Population SettingAmerican Journal of Gastroenterology, 2025
- Estimated Burden of Metabolic Dysfunction–Associated Steatotic Liver Disease in US Adults, 2020 to 2050JAMA Network Open, 2025
- Age-dependent differences in FIB-4 predictions of fibrosis in patients with MASLD referred from primary careHepatology Communications, 2024
- Association between the skeletal muscle mass to visceral fat area ratio and metabolic dysfunction‐associated fatty liver disease: A cross‐sectional study of NHANES 2017–2018Journal of Diabetes, 2024
- Metabolic dysfunction–associated steatotic liver disease: Update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver diseaseHepatology, 2023
- FIB-4 Reliability in Patients With Severe ObesityJournal of Clinical Gastroenterology, 2023
- Obesity Modifies the Performance of Fibrosis Biomarkers in Nonalcoholic Fatty Liver DiseaseThe Journal of Clinical Endocrinology & Metabolism, 2021
- Accuracy of Fibrosis-4 index and non-alcoholic fatty liver disease fibrosis scores in metabolic (dysfunction) associated fatty liver disease according to body mass index: failure in the prediction of advanced fibrosis in lean and morbidly obese individualsEuropean Journal of Gastroenterology & Hepatology, 2020
- Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver diseaseDigestive and Liver Disease, 2010
- Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfectionHepatology, 2006